NCT07714915

Brief Summary

This study aims to compare the effects of computer-controlled local anesthesia and conventional inferior alveolar nerve block on dental anxiety and pain in children undergoing pulpectomy of mandibular primary molars. Both anesthesia techniques are routinely used in pediatric dental practice and are considered standard methods of care. Children aged 6 to 8 years who require bilateral pulpectomy of mandibular primary molars will be included in this split-mouth randomized clinical trial. Each participant will receive both anesthesia techniques during separate treatment sessions. Dental anxiety, pain, and physiological parameters, including heart rate, blood pressure, oxygen saturation, and body temperature, will be assessed before, during, and after treatment using validated pediatric assessment scales and routine clinical measurements. The findings of this study may help identify the anesthesia technique that provides greater comfort and reduces anxiety and pain during pediatric dental treatment, thereby improving the overall treatment experience for children.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Jul 2026Oct 2026

First Submitted

Initial submission to the registry

July 8, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

July 9, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2026

Last Updated

July 20, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

July 8, 2026

Last Update Submit

July 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Dental Anxiety

    Dental anxiety assessed using the Modified Child Dental Anxiety Scale-faces version (MCDASf). Higher scores indicate higher levels of dental anxiety.

    Baseline and immediately after treatment

  • Behavioral Pain During Local Anesthesia

    Behavioral pain assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale during local anesthesia administration. Scores range from 0 to 10, with higher scores indicating greater pain.

    Immediately after local anesthetic injection

Secondary Outcomes (6)

  • Self-reported Pain

    Immediately after local anesthetic injection

  • Facial Image Scale (FIS) Score

    Baseline and immediately after treatment.

  • Heart Rate

    Baseline and during local anesthetic administration

  • Blood Pressure

    Baseline, during local anesthetic administration, and immediately after treatment

  • Peripheral Oxygen Saturation (SpO₂)

    Baseline, during local anesthetic administration, and immediately after treatment

  • +1 more secondary outcomes

Study Arms (2)

Conventional Inferior Alveolar Nerve Block

ACTIVE COMPARATOR
Procedure: Conventional Inferior Alveolar Nerve BlockDrug: Articaine hydrochloride with epinephrine 1:100,000Device: Standard Dental Aspirating Syringe

Computer-Controlled Local Anesthesia

ACTIVE COMPARATOR
Procedure: Computer-Controlled Local AnesthesiaDrug: Articaine hydrochloride with epinephrine 1:100,000Device: Computer-Controlled Local Anesthetic Delivery System

Interventions

A 4% articaine hydrochloride solution with epinephrine 1:100,000 was used as the local anesthetic solution in both study groups.

Computer-Controlled Local AnesthesiaConventional Inferior Alveolar Nerve Block

A conventional dental aspirating syringe was used for manual administration of the local anesthetic solution.

Conventional Inferior Alveolar Nerve Block

Conventional inferior alveolar nerve block administered with a standard dental syringe for mandibular primary molar pulpectomy.

Conventional Inferior Alveolar Nerve Block

A computer-controlled local anesthetic delivery device was used to deliver the anesthetic solution at a constant, pre-programmed injection rate.

Computer-Controlled Local Anesthesia

Computer-controlled delivery of local anesthetic for mandibular primary molar pulpectomy.

Computer-Controlled Local Anesthesia

Eligibility Criteria

Age6 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 6 to 8 years.
  • Requiring bilateral pulpectomy treatment of mandibular primary molars.
  • Frankl Behavior Rating Scale score of 3 or 4.
  • American Society of Anesthesiologists (ASA) Physical Status I.
  • No known allergy to local anesthetic agents.
  • No previous experience with dental local anesthesia.
  • No signs of acute abscess or swelling in the treatment area.
  • Parent or legal guardian able to provide written informed consent and child willing to participate.

You may not qualify if:

  • ASA Physical Status II or higher.
  • Known allergy or contraindication to local anesthetic agents.
  • Frankl Behavior Rating Scale score of 1 or 2.
  • Children receiving psychological or psychiatric treatment.
  • Physical or intellectual disabilities that could interfere with study procedures.
  • Previous experience with dental local anesthesia.
  • Presence of acute abscess, cellulitis, or diffuse swelling in the treatment area.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Recep Tayyip Erdoğan University

Merkez, Rize Province, 53020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Interventions

CarticaineEpinephrine

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ThiophenesSulfur CompoundsOrganic ChemicalsHeterocyclic Compounds, 1-RingHeterocyclic CompoundsEthanolaminesAmino AlcoholsAlcoholsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The behavioral pain assessment (FLACC score) will be performed by an independent outcome assessor who is blinded to the local anesthesia technique used. Due to the nature of the interventions, participants and treating clinicians cannot be blinded.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 20, 2026

Study Start

July 9, 2026

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

October 15, 2026

Last Updated

July 20, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations